Hans-Jürgen Mika

Title: Innovator Spotlight: Hans-Jürgen Mika

Introduction

Hans-Jürgen Mika is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, evidenced by his three patented innovations. His work primarily focuses on pharmaceutical compositions that improve the incorporation and stabilization of active ingredients.

Latest Patents

Among Hans-Jürgen Mika's latest patents is a groundbreaking pharmaceutical composition comprising Fesoterodine. This patent details a pharmaceutical granulate that includes Fesoterodine or its pharmaceutically acceptable salts and stabilizers such as sorbitol and xylitol. These components combine to create a gel matrix formed by hydroxypropyl methylcellulose, enhancing the stability and effectiveness of the active ingredient. The granulation process employed in this innovation is typically wet granulation, which aids in achieving the desired formulation.

Career Highlights

Mika's work at UCB Pharma GmbH plays a crucial role in his career trajectory. As part of a dynamic team within the company, his contributions significantly impact the development of advanced pharmaceutical products. His expertise and innovative mindset have led to the successful commercialization of his patents.

Collaborations

Throughout his career, Hans-Jürgen Mika has collaborated with several esteemed colleagues, including Christoph Arth and Michael Komenda. These partnerships have enabled him to tackle complex challenges in pharmaceutical development, further enhancing the quality and efficacy of new treatment options.

Conclusion

In summary, Hans-Jürgen Mika is a distinguished inventor whose contributions to pharmaceutical innovation, particularly in the realm of Fesoterodine compositions, highlight his expertise and commitment to enhancing healthcare solutions. His ongoing work at UCB Pharma GmbH and his collaborations with fellow innovators continue to drive advancements in the industry.